Biocidin® BROAD-
Recommended by Leading Integrative Physicians to Address Intestinal Dysbiosis and Systemic Challenges*
s and
Potent Broad-Spectrum Botanical Combination
RESEARCH SHOWS:
Laboratory and clinically tested for effectiveness for over 25 years
Recommended as nutritional support by leading practitioners addressing GI Dysbiosis, Candida, Lyme, Autism, SIBO, Winter Wellness, microbial challenges and LPS endotoxins*
Balances microbiome for healthy gut ecology
Research indicates potential in addressing biofilms and chronic/resistant cases of imbalanced terrain*
Includes botanicals to assist detoxification pathways and to address inflammation* Pleasant tasting – suitable for both children and adults
Rate of Borrelia Cell Death After Application
2,000,000 1,800,000 1,600,000 1,400,000 1,200,000 1,000,000 800,000 600,000 400 00
,000 BIOCIDIN® BIOCIDIN® LSF
“We have studied many possible treatments for Lyme at our research facility in Europe, and this is one that is a most promising candidate. Both the Liposomal format and original liquid version were tested. I think that our research supports the clinical feedback from physicians like Dr. Richard Horowitz. These formulas are a breakthrough in addressing Lyme disease, and should be considered a valuable addition to our integrative approach.” –Dr. Leona Gilbert, Ph.D.
“Biocidin has been the most comprehensive natural combination that I’ve encountered. I have been very pleased with the consistent results using it for our patients, and we put every Lyme patient on it. The new Liposomal Biocidin is a welcome addition.” –Dr. James Roach, MD
0 min 10 min 20 min 30 min Time (min) THE ORIGINAL INTERNIST BIO-BOTANICAL RESEARCH INC.
For information visit
Biocidin.com or call 800.775.4140
*These statements have not been evaluated by the Food and Drug Administration. (FDA) These products are not intended to diagnose, treat, cure or prevent any disease.
60 min 120 min
Inhibi i
includl d
Potent Broad-Spectrum Liposomal Formula
RESEARCH SHOWS:
Inhibition of all pleomorphic forms of Borrelia including Round Body and Biofilms*
Liposomal Formulation provides intracellular absorption of ingredients as verified by independent research*
Assists in delivery of broad-spectrum botanicals to the central nervous system, a key benefit when addressing Lyme disease or other pathogens*
Unilamellar Vesicles have optimal particle size of 100 nanometers
Immediate bio-availability from oral cavity
Enhances the activity of other antimicrobial agents by in inhibiting efflux mechanisms that create resistance
Cells/ml
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52
